ANXA2 and glioblastoma: The Kaplan-Meier survival analysis showed that the high expression of ANXA2 was associated with a poor PFI in ACC, BLCA, GBM, HNSC, KIRC, KIRP, LGG, LIHC, LUAD, MESO, PAAD and UVM.